Award honours decades of groundbreaking work in panel data econometrics His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and Ruler of Dubai, has ...

During an exclusive chat recently, actor Harman Singha recalled fond memories of Dhamendra Ji on the sets of Rocky Aur Rani Kii Prem Kahani. Read on Actor Harman Singha – who currently received ...

Dhurandhar, the spy thriller starring Ranveer Singh, has set the cash registers ringing since its theatrical release. The film crossed the ₹150 crore milestone within the first 5 days of its release ...

Just two years following the breakdown of her 14 year marriage, Countryfile presenter Anita Rani has shared details of her new relationship with Alex Lavery. The couple went public in September this ...

After a long wait, the internationally acclaimed and deeply cherished film Chidiya is finally ready to spread its wings once again. Following its limited theatrical release on 30th May 2025, the film ...

Rani Therapeutics Holdings, Inc. targets a new potential oral delivery of biologic drugs via the RaniPill. This could eventually replace injections and improve patient adherence. Their pipeline has RT ...

Rani Therapeutics Holdings Inc. (NASDAQ:RANI) is one of the hot stocks to buy with huge upside potential. On October 21, H.C. Wainwright analyst Brandon Folkes assumed coverage of Rani Therapeutics ...

Kate Hudson's seven-year-old daughter Rani Rose got her ears pierced. The Running Point actress proudly filmed the milestone and later posted the video on TikTok. Hudson shares Rani with her longtime ...

Rani Therapeutics is initiated at a Buy rating, driven by major pipeline advancements and strong partnership momentum. RANI secured a $1.085 billion collaboration with Chugai Pharmaceutical, ...

Oct 17 (Reuters) - Rani Therapeutics (RANI.O), opens new tab on Friday announced a licensing deal to develop and sell an oral version of Chugai Pharmaceutical's (4519.T), opens new tab experimental ...

The company will receive an upfront payment of $10 million. It could also earn up to $75 million in development milestones, $100 million in sales milestones, and single-digit royalties on future ...

SAN JOSE, Calif. - Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, announced today it has entered into a securities ...